“…1 The neovascularisation process is sustained by the secretion of various angiogenic cytokines [i.e., vascular endothelial growth factor A (VEGF-A), fibroblast growth factor 2, placental growth factor 1 and -2, interleukin 8 and transforming growth factor 1], integrin overexpression and release of high amounts of metalloproteinases (MMPs). 2,3 Highly malignant cells, because of their ability to dedifferentiate and acquire characteristics of other cell types, form de novo vascular networks (vasculogenic mimicry), the presence of which predicts poor prognosis in melanoma patients. 4 This mechanism, that can contribute to new vessel formation and favour tumour growth and invasion, has been extensively studied utilizing melanoma cell lines, although it is also observed in a variety of other tumour types, including carcinomas, sarcomas, glioblastoma and astrocytoma.…”